المؤلفون: Salmanton‑García, Jon, Marchesi, Francesco, Seval, Guldane Cengiz, Jimenez Balarezo, Moraima, Busca, Alessandro, van Doesum, Jaap, Farina, Francesca

المساهمون: Institut Català de la Salut, Busca A Stem Cell Transplant Center, AOU Citta’ della Salute e della Scienza, Turin, Italy. Salmanton-García J University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany. Marchesi F Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Farina F IRCCS Ospedale San Raffaele, Milan, Italy. Seval GC Ankara University, Ankara, Türkiye. Van Doesum J University Medical Center Groningen, Groningen, Netherlands. Jiménez M Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia), Sang - Malalties, Cèl·lules mare hematopoètiques - Trasplantació, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre hematopoyéticas, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus

وصف الملف: application/pdf

العلاقة: Frontiers in Immunology;14; https://doi.org/10.3389/fimmu.2023.1125030Test; Busca A, Salmanton-García J, Marchesi F, Farina F, Seval GC, Van Doesum J, et al. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry. Front Immunol. 2023 Feb 24;14:1125030.; https://hdl.handle.net/11351/9409Test; 000951384400001

الإتاحة: https://doi.org/10.3389/fimmu.2023.1125030Test
https://hdl.handle.net/11351/9409Test

المؤلفون: Salmanton‑García, Jon, Marchesi, Francesco, Gomes da Silva, Maria, Davila Valls, Julio, Bilgin, Yavuz M., Jimenez Balarezo, Moraima, Farina, Francesca

المساهمون: Institut Català de la Salut, Salmanton-García J University of Cologne, Faculty of Medicine, and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. University of Cologne, Faculty of Medicine, and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany. German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. Marchesi F Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Gomes da Silva M Portuguese Institute of Oncology, Lisbon, Portugal. Farina F IRCCS Ospedale San Raffaele, Milan, Italy. Dávila-Valls J Hospital Nuestra Señora de Sonsoles, Ávila, Spain. Bilgin YM Department of Internal Medicine, ADRZ, Goes, the Netherlands. Jiménez M Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Sang - Càncer, Medicaments antivírics - Ús terapèutic, COVID-19 (Malaltia) - Tractament, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents, Other subheadings::Other subheadings::/therapeutic use, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antivíricos, Otros calificadores::Otros calificadores::/uso terapéutico, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas

وصف الملف: application/pdf

العلاقة: eClinicalMedicine;58; https://doi.org/10.1016/j.eclinm.2023.101939Test; Salmanton-García J, Marchesi F, Gomes da Silva M, Farina F, Dávila-Valls J, Bilgin YM, et al. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. eClinicalMedicine. 2023 Apr;58:101939.; https://hdl.handle.net/11351/9434Test

الإتاحة: https://doi.org/10.1016/j.eclinm.2023.101939Test
https://hdl.handle.net/11351/9434Test

المؤلفون: Marchetti, Monia, Salmanton‑García, Jon, Verga, Luisa, Ráčil, Zdeněk, Jimenez Balarezo, Moraima, Cabirta Touzon, Alba, Itri, Federico, El-Ashwah, Shaimaa

المساهمون: Institut Català de la Salut, Marchetti M Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Salmanton-García J Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Cologne Excellence Cluster on Cellular Stress Responses in AgingAssociated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. El-Ashwah S Oncology Center, Mansoura University, Mansoura, Egypt. Verga L Azienda Ospedaliera San Gerardo–Monza, Monza, Italy. Università MilanoBicocca, Milan, Italy. Itri F San Luigi Gonzaga Hospital–Orbassano, Orbassano, Italy. Ráčil Z Institute of Hematology and Blood Transfusion, Prague, Czech Republic. Jiménez M, Cabirta A Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia), Medicaments immunosupressors - Ús terapèutic, Avaluació de resultats (Assistència sanitària), Trastorns mieloproliferatius - Tractament, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::enfermedades de la médula ósea::trastornos mieloproliferativos, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::factores inmunitarios::inmunosupresores, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus

وصف الملف: application/pdf

العلاقة: Therapeutic Advances in Hematology;14; https://doi.org/10.1177/20406207231154706Test; Marchetti M, Salmanton-García J, El-Ashwah S, Verga L, Itri F, Ráčil Z, et al. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. Ther Adv Hematol. 2023;14:1–15.; https://hdl.handle.net/11351/9265Test

الإتاحة: https://doi.org/10.1177/20406207231154706Test
https://hdl.handle.net/11351/9265Test

المؤلفون: Jimenez Balarezo, Moraima, Roldan Galvan, Elisa, Fernandez Naval, Candela, Medina-Gil, Daniel, Peralta Garzon, Soraya, Pujadas, Gemma, Hernández Buñuel, Cristina, Pagès Geli, Carlota, Gironella Mesa, Mercedes, Orti Pascual, Guillem, Barba Suñol, Pere, Pumarola Suñé, Tomàs, Cabirta Touzon, Alba, Catalá, Eva, Valentin, Mercedes, Orfao, Alberto, González, Marcos, Ruiz Camps, Isabel, Valcarcel Ferreiras, David, Bosch Albareda, Francesc, Hernández González, Manuel, Crespo Maull, Marta, Esperalba Esquerra, Juliana, Villacampa Javierre, Guillermo, Marin Niebla, Ana, Martínez Gallo, Mónica, Fox, Maria Laura, Abrisqueta, Pau, Campins Martí, Magda

المساهمون: Institut Català de la Salut, Jiménez M, Roldán E, Gironella M, Fox L, Orti G, Barba P, Valcárcel D, Bosch F, Abrisqueta P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Fernández-Naval C, Pumarola T, Esperalba J Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Villacampa G Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Martinez-Gallo M, Hernández M Servei d’Immunologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Medina-Gil D, Peralta-Garzón S, Pujadas G, Hernández C, Pagès C, Crespo M Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Cabirta A, Catalá E, Valentín M, Marín-Niebla A Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Orfao A Department of Medicine and Cytometry General ServiceNucleus, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain. González M Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC–CB16/12/00233 and Center for Cancer Research–IBMCC (USAL-CSIC), Salamanca, Spain. Campins M Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ruiz-Camps I Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia) - Vacunació, Immunoglobulines, Sang - Malalties, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, PHENOMENA AND PROCESSES::Immune System Phenomena::Antibody Formation::Immunogenicity, Vaccine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, FENÓMENOS Y PROCESOS::fenómenos del sistema inmunitario::formación de anticuerpos::inmunogenicidad vacunal

وصف الملف: application/pdf

العلاقة: Blood Advances;6(3); https://doi.org/10.1182/bloodadvances.2021006101Test; Jimenez M, Roldan E, Fernandez-Naval C, Villacampa G, Martinez-Gallo M, Medina-Gil D, et al. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies. Blood Adv. 2022 Feb 8;6(3):774–84.; https://hdl.handle.net/11351/8614Test; 000754263400007

الإتاحة: https://doi.org/10.1182/bloodadvances.2021006101Test
https://hdl.handle.net/11351/8614Test

المؤلفون: Blennow, Ola, Salmanton‑García, Jon, Nowak, Piotr, Lopez-Garcia, Alberto, Jimenez Balarezo, Moraima, Cabirta Touzon, Alba, van Doesum, Jaap, Itri, Federico

المساهمون: Institut Català de la Salut, Blennow O, Nowak P Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Salmanton-García J Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany. Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. Itri F Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital – Orbassano, Orbassano, Italy. Van Doesum J Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands. López-García A Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain. Jiménez M, Cabirta A Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia), Sang - Malalties, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus

وصف الملف: application/pdf

العلاقة: American Journal of Hematology;97(8); https://doi.org/10.1002/ajh.26626Test; Blennow O, Salmanton-García J, Nowak P, Itri F, Van Doesum J, López-García A, et al. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report. Am J Hematol. 2022 Aug;97(8):E312–7.; https://hdl.handle.net/11351/9362Test; 000816988100001

الإتاحة: https://doi.org/10.1002/ajh.26626Test
https://hdl.handle.net/11351/9362Test